GGrantIndex
Sort

130,381 grants matching hiv

Long-term consequences of HIV in the Kidney

$1,832,641
Paul Evan Klotman · Baylor College Of Medicine · P01 · FY2020 · DK

Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico

$1,832,422
Lisa R Metsch · Columbia University Health Sciences · R01 · FY2013 · DA

SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE

$1,832,410
David Hoos · Columbia University Health Sciences · U2G · FY2013 · PS

Lambda Genetic Networks and Lambda Red-Mediated Recombination

$1,832,266
Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES

$1,832,252
Emory University · P01 · FY2003 · AI

District of Columbia Center for AIDS Research

$1,832,040
Alan Edward Greenberg · George Washington University · P30 · FY2025 · AI

Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails

$1,831,899
Robert F Garry · La Jolla Institute For Immunology · U19 · FY2021 · AI

Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine

$1,831,862
Mary E. Klotman · Duke University · P01 · FY2018 · AI

Consultation and Collaboration

$1,831,605
Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Centers for AIDS Research (CFAR)

$1,831,319
Kent J. Weinhold · Duke University · P30 · FY2018 · AI

University of Rochester HIV/AIDS Clinical Trials Unit

$1,831,085
Michael C Keefer · University Of Rochester · UM1 · FY2024 · AI

Immunopathogenesis of acute and early HIV infection

$1,830,410
Fred Valentine · New York University School Of Medicine · P01 · FY2006 · AI

COMPREHENSIVE STRATEGY TO SCALE UP THE MILITARY ART PROGRAM TO ACHIEVE THE 95-95-95 GOALS FOR HIV EPIDEMIC CONTROL WITHIN THE MILITARY

$1,830,384
Amacach · · FY2021 · Defense Health Agency

COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)

$1,830,201
Thomas Denny · Duke University · N01 · FY2023 · AI

Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1

$1,829,883
Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

PS04-012, HIV PREVENTION PROJECTS

$1,829,867
Joy Sennett · Mississippi State Department Of Health · U62 · FY2008 · PS

Staphylococcal biofilm and disease

$1,829,495
Kenneth W. Bayles · University Of Nebraska Medical Center · P01 · FY2013 · AI

Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.

$1,828,735
Matthew A. Spinelli · University Of California, San Francisco · UH3 · FY2025 · DA

Basic Dopamine Transporter Mechanisms Of Cocaine

$1,827,786
Jonathan L Katz · National Institute On Drug Abuse · Z01 · FY2007 · DA

Cell Interactions in Three Dimensional Tissue Culture

$1,827,738
Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Scripps NeuroAIDS Preclinical Studies (SNAPS)

$1,827,569
Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2009 · MH

District of Columbia Center for AIDS Research (DC CFAR)

$1,827,364
Alan Edward Greenberg · George Washington University · P30 · FY2015 · AI

GENERAL CLINICAL RESEARCH CENTER

$1,827,311
Tufts Medical Center · M01 · FY2000 · RR

Focal Segmental Glomerulosclerosis: Genetics & Mechanisms

$1,827,056
Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Focal Segmental Glomerulosclerosis: Genetics & Mechanisms

$1,827,056
Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK